Bausch Health Companies (BHC) Profit After Tax (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Profit After Tax came in at $260.0 million in Q2 2026, up 75.68% year-over-year from $148.0 million in Q2 2025, and up 118.17% quarter-over-quarter from -$1.4 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Profit After Tax (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Profit After Tax across 18 years of filings, most recently posting $260.0 million for Q2 2026.
- In Q2 2026, Profit After Tax rose 75.68% year-over-year to $260.0 million; the TTM figure through Jun 2026 stood at -$1.1 billion (down 1720.59% YoY), while the FY2025 annual figure was $157.0 million, up 318.06% from the prior year.
- Profit After Tax came in at $260.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
- Average Profit After Tax over 5 years is -$108.1 million, with a median of -$73.0 million recorded in 2022.
- Year-over-year, Profit After Tax surged 1380.0% in 2025 and sank 1563.95% in 2026.
- Over 5 years, Profit After Tax stood at -$423.0 million in 2022, then jumped by 88.89% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then slumped by 214.29% to -$112.0 million in 2025, then jumped by 332.14% to $260.0 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $260.0 million in Q2 2026, -$1.4 billion in Q1 2026, and -$112.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 260.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -66.82 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 24.71 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 1.97 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 260.00 Mn |
| Mar 31, 2026 | -1.43 Bn |
| Dec 31, 2025 | -112.00 Mn |
| Sep 30, 2025 | 181.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | -77.00 Mn |
| Dec 31, 2023 | -47.00 Mn |
| Sep 30, 2023 | -382.00 Mn |
| Jun 30, 2023 | 27.00 Mn |
| Mar 31, 2023 | -209.00 Mn |
| Dec 31, 2022 | -423.00 Mn |
| Sep 30, 2022 | 403.00 Mn |
| Jun 30, 2022 | -145.00 Mn |
| Mar 31, 2022 | -69.00 Mn |
| Dec 31, 2021 | 69.00 Mn |
| Sep 30, 2021 | 191.00 Mn |